Comet Holding Ltd.

COTN

Equity

ISIN CH0360826991 / Valor 36082699

SIX Swiss Exchange (2026-06-26)

CHF 391.30-0.31%

Comet Holding Ltd.
UMushroom community rating:

4.00 3 votes No rating yet

NegativeNeutralPositive

About company

Comet Holding Ltd. is a Swiss-based company specializing in the development and manufacturing of innovative components and systems used in the fields of vacuum technology, radio frequency (RF) technology, and X-ray technology. The company's products are integral to a variety of applications across sectors such as semiconductor manufacturing, automotive, security, and electronics. Comet Holding's focus is on leveraging its core competencies in these areas to deliver high-quality, precision technologies that meet the evolving needs of its global clientele. The firm is recognized for its commitment to advancing technology in alignment with industry demands, thereby supporting the operational capabilities of its customers worldwide.

Summarized from source with an LLMView SourceSector: Technology

Revenue and margins

Net sales: CHF 445.4m in 2024 (2023: CHF 397.5m), up ~12.1%. Gross profit: CHF 193.1m with a gross margin of 43.4% (2023: 41.0%), reflecting margin improvement versus prior year.

Profitability and EPS

Operating income rose to CHF 38.2m (8.6% margin) from CHF 25.0m (6.3%); EBITDA increased to CHF 60.4m (2023: CHF 45.0m). Net income was CHF 35.1m (2023: CHF 15.4m), and basic/diluted EPS was CHF 4.52 (2023: CHF 1.98), i.e., more than doubled year-on-year.

Segment performance

PCT (Plasma Control Technologies) led growth: sales CHF 247.4m (2023: CHF 193.2m) and strong EBITDA contribution (segment EBITDA CHF 52.7m; margin ~21.3%). X‑Ray Systems (IXS) sales roughly stable at CHF 115.8m but reported an operating loss (CHF -8.9m). Industrial X‑Ray Modules (IXM) sales CHF 82.1m with positive contribution.

Cash flow and liquidity

Operating cash flow improved to CHF 50.0m (2023: CHF 22.3m). Cash and cash equivalents rose to CHF 113.7m (Dec 31, 2023: CHF 86.7m). CapEx was lower than prior year (PPE purchases CHF 10.3m vs CHF 24.5m).

Order backlog and working capital

Unsatisfied performance obligations (order backlog) were CHF 141m (2023: CHF 131m), mostly expected to be recognized within 12 months. Trade receivables increased to CHF 87.5m (2023: CHF 64.8m); inventories modestly higher at CHF 106.8m.

Balance sheet and equity

Total assets CHF 531.2m; total liabilities CHF 205.7m. Equity attributable to shareholders CHF 325.4m (2023: CHF 296.1m), giving an equity ratio of ~61.3% (2023: 62.5%). Net non-current debt essentially stable (~CHF 59.9m).

Notable items and risks

2024 included a net FX gain (CHF 3.2m) versus a FX loss in 2023; derivative fair-value movements were negative (CHF -1.4m). Employee benefit liabilities increased materially (CHF 12.5m vs CHF 6.8m), and actuarial losses affected other comprehensive income. Management notes industry cyclical patterns (semiconductor recovery uneven) as ongoing uncertainty.